Search

everythinglearnresearchcommunity

for

Search:↓

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Adding TPGS to minoxidil solutions can improve skin penetration and retention, especially in water and PEG 400-based solutions.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

Women are more likely to have long-term post-COVID symptoms than men.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

A new hair loss treatment was created using minoxidil and tretinoin in stable niosomes, which effectively released the drugs over time.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Bortezomib chemotherapy can cause temporary skin rashes.

Some treatments can improve skin's defense against damage, but overuse may cause other skin problems.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The African spiny mouse heals skin without scarring due to different protein activity compared to the common house mouse, which heals with scarring.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Nrf2 helps protect skin from damage but too much can cause skin problems.

The study suggests that higher levels of SIRT1 and SIRT2 may improve overall cell health and aging processes.